Enovix Q4 revenue $11.3M, FY revenue $31.8M (+38% YoY); board authorizes $75M buyback

Enovix Corp

2025-FY EPS reported -$0.75 vs consensus -$0.18 ▼ miss (-317.1%)

Q4 2025 revenue $11.3M (record, up 16% YoY from $9.7M); FY2025 revenue $31.8M (up 38% from $23.1M).
GAAP net loss per share ($0.16) in Q4, ($0.75) for FY; non-GAAP loss per share ($0.14) and ($0.54).
Non-GAAP gross margin improved to 23% in FY2025 from 0.9% in FY2024; cash & marketable securities $621M.
Smartphone qualification progressing; cycle-life high-power testing is key gating item for commercialization.
Board authorized additional $75M share repurchase; Q1 2026 revenue guidance $6.5-7.5M, non-GAAP loss from ops ($29-32M).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.